ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $21,000 | +600.0% | 1,190 | +313.2% | 0.00% | – |
| Q1 2018 | $3,000 | -50.0% | 288 | -81.0% | 0.00% | – |
| Q4 2017 | $6,000 | +500.0% | 1,513 | +397.7% | 0.00% | – |
| Q1 2017 | $1,000 | -99.0% | 304 | -99.2% | 0.00% | – |
| Q4 2016 | $98,000 | +197.0% | 38,245 | +261.1% | 0.00% | – |
| Q3 2016 | $33,000 | +10.0% | 10,592 | +11.3% | 0.00% | – |
| Q2 2016 | $30,000 | -73.7% | 9,513 | -74.2% | 0.00% | – |
| Q1 2016 | $114,000 | +50.0% | 36,825 | +94.0% | 0.00% | – |
| Q4 2015 | $76,000 | +985.7% | 18,982 | +1220.9% | 0.00% | – |
| Q3 2015 | $7,000 | -92.7% | 1,437 | -92.2% | 0.00% | – |
| Q2 2015 | $96,000 | +62.7% | 18,420 | +95.2% | 0.00% | – |
| Q1 2015 | $59,000 | -42.7% | 9,436 | -42.3% | 0.00% | – |
| Q4 2014 | $103,000 | +312.0% | 16,344 | +291.4% | 0.00% | – |
| Q3 2014 | $25,000 | +1150.0% | 4,176 | +1234.2% | 0.00% | – |
| Q2 2014 | $2,000 | -99.7% | 313 | -98.9% | 0.00% | -100.0% |
| Q1 2014 | $665,000 | +127.0% | 27,907 | +1.7% | 0.00% | – |
| Q4 2013 | $293,000 | +4.3% | 27,440 | +30.2% | 0.00% | – |
| Q3 2013 | $281,000 | +16.6% | 21,070 | +14.6% | 0.00% | – |
| Q2 2013 | $241,000 | – | 18,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |